非抗肿瘤产品
非抗肿瘤产品 紫杉烷类产品 抗肿瘤产品 潜力产品 植物提取物
Taxanes Product List ,2023
APIs
Product code
 API name
原料药中文名称
CAS No.
Indications and Usage
适应症
Specification Regulatory Documentation GMP STATUS
Open Part Tech Pack CMC NMPA CDE Status CEP USDMF DMF No.
NMPA
GMP
International GMP
902
Paclitaxel
半合成紫杉醇
33069-62-4
Oncology
抗肿瘤
USP、EP、CP     A
USDMF#25822
R0-CEP 2019-110-Rev 02
CDE#Y20190000514
COFEPRIS GMP
903
Docetaxel anhydrous
多西他赛无水
114977-28-5
Oncology
抗肿瘤
USP、EP、CP     A
USDMF#25295
R0-CEP 2016-204-Rev 02
CDE#Y20170001931
EU-GMP
904
Docetaxel Trihydrate
多西他赛三水
148408-66-6
Oncology
抗肿瘤
USP、EP、CP     I   CDE#Y20180001153    
Taxanes Intermediate
Product 
code
Intermediate name CAS No. Taxanes Specification   Tech Pack CMC       DMF No.    
905 10-Deacetyl BaccatinIII 32981-86-5 KSM for Paclitaxel,Docetaxel,Cabazitaxel  In-house       USDMF# 25294    
902-I1 Baccatin III 27548-93-2 Paclitaxel  In-house              
902N-1 7-Troc Paclitaxel 114915-17-2 Paclitaxel  In-house              
903 I1 7,10-DiTroc-10-DAB III 95603-44-4 Docetaxel In-house              
903N-1 7,10-Di Troc Docetaxel 114915-14-9 Docetaxel In-house              
910-D
(4S,5R)-3-(tert-Butoxycarbonyl)-2,2-
dimethyl-4-phenyloxazolidine-5-
carboxylic acid 
143527-70-2 Docetaxel In-house              
912
(4S,5R)-3-benzoyl-2-(4-methoxyphenyl)-4-
phenyl-5-oxazolidinecarboxylic acid
949023-16-9 Paclitaxel  In-house              
913
(4S,5R)-3-tert-butoxycarbonyl-2-
(4-anisyl)-4-phenyl-5-oxazolidinecarboxylic acid
196404-55-4 Docetaxel In-house              
917-D (3R,4S)-3-triethylsilanyloxy-4-phenyl-N-Boc-2-azetidinone 149198-47-0 Docetaxel,Cabazitaxel In-house              
918-I3
(3R,4S)-3-hydroxy-4-phenyl-
azetidin-2-one 
132127-34-5 Paclitaxel,Docetaxel In-house              
918
(3R,4S)-3-(1-ethoxyethoxy)-4-phenyl
-N-benzoyl-2-azetidinone
201856-53-3 Paclitaxel  In-house              

分享:

南方制药官方微信

南方制药官方微信